Placido Rojas-Franco

Placido Rojas-Franco

Auto-generated profile, based on publicly available information

Placido Rojas-Franco


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2022 in Pharmaceutical Biology
Verified
Journal Article
Open access
VBVanessa Blas-Valdivia
Vanessa Blas-Valdivia
DMDaniela Nikita Moran-Dorantes
Daniela Nikita Moran-Dorantes
PRPlacido Rojas-Franco
Placido Rojas-Franco
MFMargarita Franco-Colín
Margarita Franco-Colín
NMNeda Mirhosseini
Neda Mirhosseini
ECEdgar CANO-EUROPA
Edgar CANO-EUROPA
C-Phycocyanin is a protein with anti-scavenger, antioxidant and anti-inflammatory actions against agents that cause cellular damage. The cardioprotective action of C-phycocyanin against acute myoca...

5 March 2021 in Food & Function
Verified
Journal Article
Closed access
PDF file
EPErick García Pliego
Erick García Pliego
MFMargarita Franco-Colín
Margarita Franco-Colín
PRPlácido Rojas-Franco
Plácido Rojas-Franco
VBVanessa Blas-Valdivia
Vanessa Blas-Valdivia
JOSE IVAN SERRANO CONTRERASJOSE IVAN SERRANO CONTRERAS
JOSE IVAN SERRANO CONTRERAS
ECEdgar CANO-EUROPA
Edgar CANO-EUROPA
C-Phycocyanin (CPC) exerts therapeutic, antioxidant, anti-inflammatory and immunomodulatory actions. It prevents oxidative stress and acute kidney damage caused by HgCl2. However, the exact mechanism of the pharmacological action of C-phycocyanin is as yet unclear. Some proposals express that CPC metabolism releases the active compound phycocyanobilin (PCB) that is able to induce CPC's therapeutical effects as an antioxidant, anti-inflammatory and nephroprotective. This study is aimed to demonstrate that PCB is the molecule responsible for C-phycocyanin's nephroprotective action in the acute kidney injury model caused by HgCl2. PCB was purified from C-phycocyanin and characterized by spectroscopy and mass spectrometry methods. Thirty-six male mice were administrated with 0.75, 1.5, or 3 mg per kg per d of PCB 30 min before the 5 mg kg−1 HgCl2 administration. PCB was administered during the following five days, after which the mice were euthanized. Kidneys were dissected to determine oxidative stress and redox environment markers, first-line antioxidant enzymes, effector caspase activities, and kidney damage markers.The quality of purified PCB was evaluated by spectroscopy and mass spectrometry. All PCB doses prevented alterations in oxidative stress markers, antioxidant enzymes, and caspase 9 activities. However, only the dose of 3 mg per kg per d PCB avoided the redox environment disturbance produced by mercury. All doses of PCB partially prevented the down-expression of nephrin and podocin with a consequent reduction in the damage score in a dose-effect manner. In conclusion, it was proven that phycocyanobilin is the molecule responsible for C-phycocyanin's nephroprotective action on acute kidney injury caused by mercury.

1 January 2019 in Renal Failure
Verified
Journal Article
Open access
PRPlácido Rojas-Franco
Plácido Rojas-Franco
MFMargarita Franco-Colín
Margarita Franco-Colín
ATAlejandra Paola Torres-Manzo
Alejandra Paola Torres-Manzo
VBVanessa Blas-Valdivia
Vanessa Blas-Valdivia
MTMaría del Rocio Thompson-Bonilla
María del Rocio Thompson-Bonilla
ECEdgar CANO-EUROPA
Edgar CANO-EUROPA
Acute exposure to mercury chloride (HgCl2) causes acute kidney injury (AKI). Some metals interfere with protein folding, leading to endoplasmic reticulum stress (ERS), and the activation of cell death mechanisms, but in the case of mercury, there is no knowledge about whether the ERS mediates tubular damage. This study aimed to determinate if HgCl2 causes an AKI course with temporary activation of ERS and if this mechanism is involved in kidney cell death. Male mice were intoxicated with 5 mg/kg HgCl2 and sacrificed after 24, 48, 72, and 96 h of mercury administration. The kidneys of euthanized mice were used to assess the renal function, oxidative stress, redox environment, antioxidant enzymatic system, cell death, and reticulum stress markers (PERK, ATF-6, and IRE1α pathways). The results indicate temporary-dependent renal dysfunction, oxidative stress, and an increase of glutathione-dependent enzymes involved in the bioaccumulation process of mercury, as well as the enhancement of caspase 3 activity along with IRE1a, GADD-153, and caspase 12 expressions. Mercury activates the PERK/eIF2α branch during the first 48 h. Meanwhile, the activation of PERK/ATF-4 branch allowed for ATF-4, ATF-6, and IRE1α pathways to enhance GADD-153. It led to the activation of caspases 12 and 3, which mediated the deaths of the tubular and glomerular cells. This study revealed temporary-dependent ERS present during AKI caused by HgCl2, as well as how it plays a pivotal role in kidney cell damage.

20 October 2021 in Marine Drugs
Verified
Journal Article
Open access
PDF file
VBVanessa Blas-Valdivia
Vanessa Blas-Valdivia
PRPlácido Rojas-Franco
Plácido Rojas-Franco
JOSE IVAN SERRANO CONTRERASJOSE IVAN SERRANO CONTRERAS
JOSE IVAN SERRANO CONTRERAS
ASAndrea Augusto Sfriso
Andrea Augusto Sfriso
CGCristian Garcia-Hernandez
Cristian Garcia-Hernandez
ECEdgar CANO-EUROPA
Edgar CANO-EUROPA
C-phycoerythrin (C-PE) is a phycobiliprotein that prevents oxidative stress and cell damage. The aim of this study was to evaluate whether C-PE also counteracts endoplasmic reticulum (ER) stress as a mechanism contributing to its nephroprotective activity. After C-PE was purified from Phormidium persicinum by using size exclusion chromatography, it was characterized by spectrometry and fluorometry. A mouse model of HgCl2-induced acute kidney injury (AKI) was used to assess the effect of C-PE treatment (at 25, 50, or 100 mg/kg of body weight) on oxidative stress, the redox environment, and renal damage. ER stress was examined with the same model and C-PE treatment at 100 mg/kg. C-PE diminished oxidative stress and cell damage in a dose-dependent manner by impeding the decrease in expression of nephrin and podocin normally caused by mercury intoxication. It reduced ER stress by preventing the activation of the inositol-requiring enzyme-1α (IRE1α) pathway and avoiding caspase-mediated cell death, while leaving the expression of protein kinase RNA-like ER kinase (PERK) and activating transcription factor 6α (ATF6α) pathways unmodified. Hence, C-PE exhibited a nephroprotective effect on HgCl2-induced AKI by reducing oxidative stress and ER stress.

31 March 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
PRPlacido Rojas-Franco
Placido Rojas-Franco
EPErick García Pliego
Erick García Pliego
AVAlma Gricelda Vite-Aquino
Alma Gricelda Vite-Aquino
MFMargarita Franco-Colín
Margarita Franco-Colín
JOSE IVAN SERRANO CONTRERASJOSE IVAN SERRANO CONTRERAS
JOSE IVAN SERRANO CONTRERAS
ECEdgar CANO-EUROPA
Edgar CANO-EUROPA
C-phycocyanin (CPC) is an antihypertensive that is not still wholly pharmacologically described. The aim of this study was to evaluate whether CPC counteracts endothelial dysfunction as an antihypertensive mechanism in rats with 5/6 nephrectomy (NFx) as a chronic kidney disease (CKD) model. Twenty-four male Wistar rats were divided into four groups: sham control, sham-treated with CPC (100 mg/Kg/d), NFx, and NFx treated with CPC. Blood pressure was measured each week, and renal function evaluated at the end of the treatment. Afterward, animals were euthanized, and their thoracic aortas were analyzed for endothelium functional test, oxidative stress, and NO production. 5/6 Nephrectomy caused hypertension increasing lipid peroxidation and ROS production, overexpression of inducible nitric oxide synthase (iNOS), reduction in the first-line antioxidant enzymes activities, and reduced-glutathione (GSH) with a down-expression of eNOS. The vasomotor response reduced endothelium-dependent vasodilation in aorta segments exposed to acetylcholine and sodium nitroprusside. However, the treatment with CPC prevented hypertension by reducing oxidative stress, NO system disturbance, and endothelial dysfunction. The CPC treatment did not prevent CKD-caused disturbance in the antioxidant enzymes activities. Therefore, CPC exhibited an antihypertensive activity while avoiding endothelial dysfunction.

Verified
Journal Article
Open access
PDF file
ZMZayra Mundo-Franco
Zayra Mundo-Franco
JLJulieta Luna-Herrera
Julieta Luna-Herrera
JCJorge Castañeda
Jorge Castañeda
JOSE IVAN SERRANO CONTRERASJOSE IVAN SERRANO CONTRERAS
JOSE IVAN SERRANO CONTRERAS
PRPlácido Rojas-Franco
Plácido Rojas-Franco
ECEdgar CANO-EUROPA
Edgar CANO-EUROPA
Asthma is a chronic immunological disease related to oxidative stress and chronic inflammation; both processes promote airway remodeling with collagen deposition and matrix thickening, causing pulmonary damage and lost function. This study investigates the immunomodulation of C-phycocyanin (CPC), a natural blue pigment purified from cyanobacteria, as a potential alternative treatment to prevent the remodeling process against asthma. We conducted experiments using ovalbumin (OVA) to induce asthma in Sprague Dawley rats. Animals were divided into five groups: (1) sham + vehicle, (2) sham + CPC, (3) asthma + vehicle, (4) asthma + CPC, and (5) asthma + methylprednisolone (MP). Our findings reveal that asthma promotes hypoxemia, leukocytosis, and pulmonary myeloperoxidase (MPO) activity by increasing lipid peroxidation, reactive oxygen and nitrogen species, inflammation associated with Th2 response, and airway remodeling in the lungs. CPC and MP treatment partially prevented these physiological processes with similar action on the biomarkers evaluated. In conclusion, CPC treatment enhanced the antioxidant defense system, thereby preventing oxidative stress and reducing airway inflammation by regulating pro-inflammatory and anti-inflammatory cytokines, consequently avoiding asthma-induced airway remodeling.